BPC January 14 update

Revelation REVB COVID-19 data; Molecular MOLN Analyst PT raised

Pre-Market Updates

Revelation Biosciences, Inc. (NASDAQ: REVB) reported data demonstrating REVTx-99 in vitro anti-viral activity against SARS-CoV-2. A greater than 50% reduction in SARS-CoV-2 Delta viral load was observed.

SVB Leerink maintained Molecular Partners (NASDAQ: MOLN) with an Outperform and raised the price target from $35 to $42. Molecular also reported a disclosure of major shareholders as per Swiss Stock Exchange regulations.

Solid Biosciences Inc. (NASDAQ: SLDB) pushed back its data readout for its IGNITE Phase 1/2 trial of SGT-001 to treat Duchenne Muscular Dystrophy in a blog post on the company website last night. Data is now due in the first half of 2022 rather than early 2022.

Covid-19 vaccine makers continued to decline in the pre-market today after the US Supreme Court (SCOTUS) blocked President Biden's workplace vaccine-or-test mandate for larger employers. Moderna (NASDAQ: MRNA), BioNTech (NASDAQ: BNTX), and Novavax (NASDAQ: NVAX) all are trading down.

RedHill Biopharma Ltd. (NASDAQ: RDHL) announced new data from a prespecified analysis of all oral opaganib's Phase 2/3 study patients in COVID-19 patients noting that opaganib improved the median time to viral RNA clearance by at least four days.

Celsion Corporation (NASDAQ: CLSN) announced the closing of its registered direct offering of Series A preferred stock and 50,000 shares of Series B preferred stock. Net proceeds of the offering were approximately $28.5 million.

Galapagos NV (NASDAQ: GLPG) announced that its supervisory board created 30,000 subscription rights under a new employee subscription right plan. Under this subscription right plan, 30,000 subscription rights were created.

Pre-Market Advancers

CompanyPriceChange
CGTX
Cognition Therapeutics Inc.
$4.30+0.8  +22.86%
HOOK
HOOKIPA Pharma Inc.
$1.79+0.29  +19.33%
MRKR
Marker Therapeutics Inc.
$0.71+0.11  +18.33%
IMMX
Immix Biopharma Inc.
$5.31+0.8  +17.74%
BSGM
BioSig Technologies Inc.
$2.10+0.3  +16.67%
CALA
Calithera Biosciences Inc.
$0.52+0.0678  +14.99%
PALI
Palisade Bio Inc.
$1.21+0.155  +14.69%
RMTI
Rockwell Medical Inc.
$0.45+0.0568  +14.45%
VRPX
Virpax Pharmaceuticals Inc.
$2.63+0.3301  +14.35%
NRBO
NeuroBo Pharmaceuticals Inc.
$1.28+0.16  +14.29%

Pre-Market Decliners

CompanyPriceChange
ARDS
Aridis Pharmaceuticals Inc.
$1.32-0.28  -17.50%
HILS
Hillstream BioPharma Inc.
$2.89-0.47  -13.99%
CINC
CinCor Pharma Inc.
$15.66-2.54  -13.96%
RUBY
Rubius Therapeutics Inc.
$6.54-0.7615  -10.43%
GMDA
Gamida Cell Ltd.
$2.95-0.29  -8.95%
KPTI
Karyopharm Therapeutics Inc.
$7.63-0.65  -7.85%
BDSI
BioDelivery Sciences International Inc.
$3.10-0.26  -7.74%
ITCI
Intra-Cellular Therapies Inc.
$39.57-3.09  -7.24%
BNTC
Benitec Biopharma Inc.
$2.31-0.18  -7.23%
VAXX
Vaxxinity Inc.
$7.57-0.59  -7.23%